Related Experiment Video
Updated: Feb 14, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Simultaneous Down-Regulation of Intracellular hTERT and GPX4 mRNA Using MnO2-Nanosheet Probes to Induce Cancer Cell
Yixin Miao1, Tao Zhou1, Qinghong Ji1
1School of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng 252059, China.
Abstract:
Cancer remains a leading global cause of death, with conventional treatments often limited by toxicity and recurrence. Recent advances in gene therapy and nanodrug delivery offer new avenues for precision oncology. Human telomerase reverse transcriptase (hTERT) and glutathione peroxidase 4 (GPX4) are overexpressed in many cancers and linked to apoptosis and ferroptosis, respectively. Here, we developed a manganese dioxide nanosheet (MnO2-NS) probe co-loaded with antisense oligonucleotides targeting hTERT and GPX4 mRNA to synergistically down-regulate both genes and induce dual cell death pathways. The probe, assembled via adsorption of fluorescently labeled antisense strands, showed controllable release in the presence of glutathione (GSH). Cellular uptake and antisense release were confirmed in multiple cancer cell lines. The MnO2-NS probe significantly suppressed cell proliferation, outperforming single-target or carrier-only controls. Molecular analyses confirmed reduced hTERT and GPX4 expression, along with GSH depletion, ROS accumulation, and elevated lipid peroxidation-collectively promoting enhanced cancer cell death. In summary, this MnO2-NS-based co-delivery system enables synergistic gene silencing and GSH depletion, enhancing antitumor efficacy and providing a promising strategy for multifunctional nanotherapy.
Insights
This study introduces a novel manganese dioxide nanosheet probe that delivers gene therapy to target cancer cells. The nanotherapy effectively suppresses tumor growth by simultaneously down-regulating key cancer genes and depleting glutathione.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Cancer poses a significant global health challenge, with conventional therapies facing limitations in efficacy and tolerability.
- Gene therapy and nanodrug delivery represent emerging strategies for precision oncology.
- Overexpression of human telomerase reverse transcriptase (hTERT) and glutathione peroxidase 4 (GPX4) is implicated in cancer progression and resistance to cell death.
Purpose of the Study:
- To develop a multifunctional nanoplatform for synergistic cancer treatment.
- To co-deliver antisense oligonucleotides targeting hTERT and GPX4 mRNA using manganese dioxide nanosheets (MnO2-NS).
- To investigate the combined effects of gene silencing and glutathione depletion on cancer cell death.
Main Methods:
- Fabrication of MnO2-NS probes loaded with fluorescently labeled antisense oligonucleotides against hTERT and GPX4 mRNA.
- Demonstration of glutathione (GSH)-responsive release of antisense oligonucleotides.
- Assessment of cellular uptake, gene silencing efficacy, and induction of apoptosis and ferroptosis in cancer cell lines.
- Evaluation of antitumor efficacy in vitro compared to single-target or carrier-only controls.
Main Results:
- The MnO2-NS probe demonstrated efficient cellular uptake and controlled release of antisense oligonucleotides in the presence of GSH.
- Co-delivery of antisense oligonucleotides significantly suppressed cancer cell proliferation.
- Molecular analyses confirmed successful down-regulation of hTERT and GPX4 expression.
- The treatment led to GSH depletion, increased reactive oxygen species (ROS) accumulation, and enhanced lipid peroxidation, promoting synergistic cancer cell death.
Conclusions:
- The developed MnO2-NS-based co-delivery system effectively achieves synergistic gene silencing and GSH depletion.
- This multifunctional nanotherapy enhances antitumor efficacy by inducing dual cell death pathways.
- The study presents a promising nanotherapeutic strategy for precision oncology.
More Related Videos
Related Concept Videos
Regulated mRNA Transport
Regulated mRNA Transport
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
GTPases and their Regulation
Large G-proteins,...

